Research suggests new way to thwart Burkitt lymphoma
Burkitt lymphoma—one of the most aggressive tumors—may be treatable with agents that can stop cell proliferation and induce cell death by reactivating two key proteins.
Lymphoma
Cancer costs will reach or exceed $158 billion in 2020
If the US population ages at the rate predicted by the US Census Bureau and cancer incidence, survival rates, and costs remain stable, in the year 2020 direct cancer care expenditures will reach $157.77 billion in 2010 dollars.
Brentuximab shrunk tumors in resistant Hodgkin lymphoma
An investigational agent for the treatment of Hodgkin lymphoma has yielded very strong results in a phase II trial of heavily pretreated persons with relapsed or refractory disease.
Malignancies in children linked to TNF blockers
Children using tumor necrosis factor-alpha (TNF) blockers may experience an increase risk of malignancy, according to an investigation conducted by researchers from the FDA.
Doxorubicin
Doxorubicin is an anthracycline antibiotic that is used to treat lymphoblastic and acute myeloblastic leukemias, several types of cancer, Kaposi sarcoma related to AIDS, malignant lymphoma, soft tissue and osteogenic sarcomas, and Wilms tumor.
Targeted therapy kills lymphoma cells, leaves healthy cells alone
Researchers from the Ontario Cancer Institute (OCI) have discovered a way to destroy a cancer-causing protein using a chemical compound.
Tiny compound kills large B cell lymphomas
Small molecules may help researchers develop a targeted therapy for lymphoma, according to a study published in Cancer Cell (2010;17(4):400-411).
Managing superior vena cava compression
Reviews the causes, the features, and the management of superior vena cava compression due to malignancy
Poor Survival in Lymphoma Patients Linked to Vitamin D Deficiency
Low levels of vitamin D has been linked to poor prognosis in patients with aggressive lymphoma, according to a new study presented at the American Society of Hematology Annual Meeting and Exposition in New Orleans in December.
-
Loading...
-
Loading...
